You are here
Biomarkers
Screening, prognostic, predictive and diagnostic biomarkers. Non-invasive and tissue-based cancer biomarkers are available for licensing or collaborative development.
Over 1.3 million people worldwide are diagnosed with lung cancer each year and over a million die.
Read moreThe integrin avß6 is an exciting emerging target for both imaging and therapy across many common tumour types including pancreatic, breast, oesophagus, head and neck, skin, lung and ovarian.
Read moreThe Tyrer-Cuzick model is a breast cancer risk assessment tool incorporating family history, endogenous hormonal factors, benign disease, risk factors such as age and body mass index, as well as ge
Read more